MIAT

MIAT is a specialized Italian pharmaceutical and medical device company founded in 1970 and headquartered in Milan. The company focuses primarily on the respiratory therapeutic area, developing and commercializing inhalation therapies for chronic conditions such as asthma and COPD. A key differentiator for MIAT is its proprietary dry powder inhaler (DPI) technology, known as the Miat-Haler, which it utilizes for its own portfolio and offers to partners. In addition to its respiratory focus, the company manages a niche portfolio of cardiovascular and central nervous system (CNS) products. MIAT operates internationally through licensing agreements and the distribution of active pharmaceutical ingredients (APIs) and finished dosage forms.